Copyright
©The Author(s) 2020.
World J Clin Cases. Nov 6, 2020; 8(21): 5235-5249
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5235
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5235
Table 2 Summary of the authors’ assessment of the risk of bias for each item in the Cochrane quality assessment
Ref. | Selection bias (sequence generation) | Selection bias (allocation concealment) | Performance bias (blinding) | Detection bias | Attrition bias (incomplete outcomes data) | Reporting bias (selective outcome reporting) | Other bias |
Yin et al[23], 2000 | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Low risk | Low risk | Low risk |
Poongothai et al[25], 2005 | High risk | High risk | High risk | High risk | Low risk | Low risk | Low risk |
Arvind et al[26], 2006 | High risk | High risk | Unclear risk | Unclear risk | Low risk | Low risk | Low risk |
Sun et al[21], 2008 | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Low risk | Low risk | Low risk |
Wu et al[22], 2009 | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Low risk | Low risk | Low risk |
Li et al[18], 2013 | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Low risk | Low risk | Low risk |
Sas et al[19], 2013 | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Low risk |
Dajani et al[24], 2015 | High risk | High risk | High risk | High risk | Low risk | Unclear risk | Low risk |
Shan et al[20], 2015 | Unclear risk | Unclear risk | Unclear risk | Unclear risk | Low risk | Low risk | Low risk |
Li et al[17], 2017 | Low risk | Unclear risk | Unclear risk | Unclear risk | Low risk | Low risk | Low risk |
- Citation: Dajani AI, Popovic B. Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis. World J Clin Cases 2020; 8(21): 5235-5249
- URL: https://www.wjgnet.com/2307-8960/full/v8/i21/5235.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i21.5235